Outlook Not So Rosy: Women’s Broken Bones Linked to Rosiglitazone (Avandia)


By: Linda von Wartburg

The FDA and GlaxoSmithKline, Avandia’s manufacturer, have advised doctors to carefully consider fracture risk before beginning Avandia therapy for women with type 2 diabetes.

Compared to women who received metformin or glyburide, a large study found that significantly more women who received Avandia suffered fractures of the arm, hand, and foot. There was no increase in hip or spine fractures.  Recently, GlaxoSmithKline reviewed fracture data from a currently ongoing study designed to evaluate cardiovascular safety of Avandia. The fracture data thus far corroborated the earlier results, leading to the current warning. 

Source:  Medpagetoday.com



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.